A man from Brighton has spoken out after the NHS agreed to offer a life-extending drug to more men with prostate cancer. Currently only those with prostate cancer that has spread can get abiraterone ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...

The NHS has expanded access to a prostate cancer drug across England in a move which could stop 8,000 former cancer patients from being told their illness has returned.

In early 2024, an unusually candid decision inside Buckingham Palace reshaped public discussion of cancer, men's health, and ...

An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

An oncology dietitian has warned cancer patients against using a popular alternative cancer treatment, as it 'doesn't work' ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

A new report from the American Cancer Society shows 7 in 10 cancer patients are living at least 5 years post-diagnosis.